European Journal of Organic Chemistry
10.1002/ejoc.201601271
FULL PAPER
(
2R,4S,5S)-N’,4,5-triphenyl-2-(pyridin-2-yl)imidazolidine-1-
155.5 (C), 149.6 (CH), 139.9 (C), 139.4 (C), 138.8 (CH), 138.1 (C), 137.3
(C), 129.0 (CH), 128.9 (CH), 128.5 (CH), 127.9 (CH), 127.4 (CH), 126.9
(CH), 124.2 (CH), 122.7 (CH), 121.6 (CH), 121.1 (CH), 119.3 (CH), 76.9
(CH), 70.9 (CH), 69.8 (CH). IR: 3288, 3240, 3056, 3029, 2892, 1665,
1596, 1581, 1536, 1498, 1442, 1428, 1318, 1245, 1146, 1072, 992, 903,
carboxamide 2a-(2R,4S,5S). Following general procedure for the
preparation of platforms, the compound 2a-(2R,4S,5S) was obtained as a
1
white powder with a yield of 77 %. R
NMR (300 MHz, CDCl
7
3
8
f
= 0.75 (AcOEt). Mp = 103 °C. H
3
) δ = 9.83 (s, 1H), 8.74 (d, J = 4.8 Hz, 1H), 7.90-
.85 (m, 2H), 7.39-7.32 (m, 8H), 7.25 (t, J = 7.6 Hz, 2H), 7.19-7.13 (m,
H), 7.02-6.93 (m, 3H), 6.22 (s, 1H), 5.07 (d, J = 8.6 Hz, 1H), 4.38 (d, J =
-1
+
748, 695, 632, 618, 554, 532, 506 cm . HRMS (ESI ) m/z calcd. for
+
32 28 5
C H N O [M + H] : 498.2294; found: 498.2291.
13
3
.6 Hz, 1H), 3.30 (s, 1H). C NMR (75 MHz, CDCl ) δ = 160.7 (C), 155.7
(C), 149.0 (CH), 140.1 (C), 139.9 (C), 137.9 (CH), 137.9 (C), 128.9 (CH),
(2S,4R,5R)-N’-(3,5-bis(trifluoromethyl)phenyl)-4,5-diphenyl-2-
1
1
3
1
28.7 (CH), 128.5 (CH), 127.6 (CH), 127.4 (CH), 126.8 (CH), 123.3 (CH),
22.4 (CH), 120.8 (CH), 119.1 (CH), 76.8 (CH), 70.7 (CH), 69.7 (CH). IR:
294, 3059, 3021, 2898, 1666, 1593, 1553, 1498, 1444, 1321, 1254,
(
pyridin-2-yl)imidazolidine-1-carboxamide 2e. Following general
procedure for the preparation of platforms, the compound 2e was
obtained as a white powder with 65 % yield. R
1
f
= 0.44 (AcOEt/pentane
) δ = 11.49 (s, 1H), 8.80 (d,
-1
+
135, 1002, 904, 748, 695, 618, 533, 506 cm . HRMS (ESI ) m/z calcd.
1
/4). Mp = 112 °C. H NMR (300 MHz, CDCl
3
+
for C27
H
25
N
4
O [M + H] : 421.2028; found: 421.2022. [α]
).
D
-181 (c 0.9,
J = 3.4 Hz, 1H), 7.96-7.89 (m, 4H), 7.45 (s, 2H), 7.38-7.33 (m, 5H), 7.13
CHCl ). [α]578 -186 (c 0.9, CHCl
3
3
(d, J = 3.0 Hz, 3H), 6.86 (s, 2H), 6.24 (s, 1H), 5.11 (d, J = 9.0 Hz, 1H),
13
4
3
.32 (d, J = 8.4 Hz, 1H), 3.22 (s, 1H). C NMR (75 MHz, CDCl ) δ =
(2S,4R,5R)-N’,4,5-triphenyl-2-(pyridin-2-yl)imidazolidine-1-
160.4 (C), 155.4 (C), 149.0 (CH), 141.7 (C), 139.7 (C), 138.5 (CH), 137.1
carboxamide 2b-(2S,4R,5R). Following general procedure for the
(C), 132.1 (q, J = 33 Hz, C), 129.1 (CH), 128.8 (CH), 128.7 (CH), 127.6
preparation of platforms, the compound 2b-(2S,4R,5R) was obtained as
(CH), 127.4 (CH), 126.4 (CH), 123.7 (CH), 123.5 (q, J = 271 Hz, C),
1
19
a white powder with a yield of 85 %. R
NMR (300 MHz, CDCl
f
= 0.75 (AcOEt). Mp = 103 °C. H
120.3 (CH), 118.9 (CH), 115.3 (CH), 76.9 (CH), 70.8 (CH), 69.6 (CH).
NMR (188 MHz, CDCl /CHF
1676, 1588, 1473, 1447, 1337, 1318, 1275, 1170, 1124, 946, 879, 843,
F
3
) δ = 9.94 (s, 1H), 8.75 (d, J = 4.6 Hz, 1H), 7.90-
.85 (m, 2H), 7.44-7.33 (m, 8H), 7.25 (t, J = 6.1 Hz, 2H), 7.17-7.13 (m,
H), 7.00-6.97 (m, 3H), 6.21 (s, 1H), 5.07 (d, J = 8.7 Hz, 1H), 4.38 (d, J =
3
3
) δ = -63.45. IR: 3304, 3064, 3032, 2905,
7
3
8
1
1
7
-
1
+
754, 697, 681, 619 cm . HRMS (ESI ) m/z calcd. for C29
H
23
F
6
N
4
O [M +
1
6
+
.4 Hz, 1H), 3.31 (s, 1H). H NMR (300 MHz, DMSO-d ) δ = 10.67 (s,
H), 8.88 (d, J = 4.5 Hz, 1H), 8.00 (t, J = 7.7 Hz, 1H), 7.89 (d, J = 7.8 Hz,
H), 7.52-7.48 (m, 3H), 7.40-7.36 (m, 5H), 7.30 (t, J = 7.6 Hz, 2H), 7.12-
.10 (m, 3H), 6.95 (t, J = 7.3 Hz, 1H), 6.80-6.83 (m, 2H), 6.16 (d, J = 7.4
H] : 557.1776; found: 557.1774. [α]
1.0, CHCl ).
+161 (c 1.0, CHCl ). [α]578 +169 (c
D 3
3
(2S,4R,5R)-N’-(3,5-bis(trifluoromethyl)phenyl)-4,5-diphenyl-2-
Hz, 1H), 4.91 (d, J = 8.9 Hz, 1H), 4.61 (dd, J = 12.5 and 7.5 Hz, 1H), 4.18
(
pyridin-2-yl)imidazolidine-1-carbothioamide 2f-(2S,4R,5R). Following
13
(dd, J = 12.3 and 9.1 Hz, 1H). C NMR (75 MHz, CDCl
3
) δ = 160.7 (C),
general procedure for the preparation of platforms, the compound 2f-
(
0
1
7
1
155.7 (C), 149.0 (CH), 140.1 (C), 139.9 (C), 137.9 (CH), 137.8 (C), 128.9
2S,4R,5R) was obtained as a white powder with a yield of 84 %. R
f
=
1
(
(
(
CH), 128.7 (CH), 128.5 (CH), 127.6 (CH), 127.4 (CH), 126.7 (CH), 123.3
.50 (AcOEt/pentane 1/4). Mp = 143 °C. H NMR (300 MHz, CDCl
3
) δ =
CH), 122.4 (CH), 120.7 (CH), 119.1 (CH), 76.7 (CH), 70.7 (CH), 69.6
2.91 (s, 1H), 8.82 (d, J = 4.5 Hz, 1H), 8.23 (s, 2H), 7.99-7.94 (m, 2H),
.55 (s, 1H), 7.49 (t, J = 5.8 Hz, 1H), 7.41 (s, 5H), 7.13 (s, 1H), 7.12 (s,
13
6
CH). C NMR (75 MHz, DMSO-d ) δ = 160.8 (C), 154.9 (C), 149.0 (CH),
1
1
1
2
1
41.0 (C), 140.2 (C), 138.3 (CH), 137.9 (C), 128.7 (CH), 128.5 (CH),
28.0 (CH), 127.6 (CH), 126.8 (CH), 126.2 (CH), 123.3 (CH), 121.7 (CH),
20.0 (CH), 118.4 (CH), 76.8 (CH), 70.6 (CH), 69.0 (CH). IR: 3307, 3022,
908, 2844, 2806, 1670, 1622, 1593, 1561, 1498, 1446, 1364, 1330,
H), 7.11 (s, 1H), 6.77 (s, 1H), 6.76 (s, 1H), 6.56 (d, J = 6.7 Hz, 1H), 5.63
13
(d, J = 9.1 Hz, 1H), 4.44 (t, J = 9.6 Hz, 1H), 3.42 (t, J = 7.7 Hz, 1H).
C
NMR (75 MHz, CDCl
3
) δ = 181.1 (C), 159.3 (C), 148.6 (CH), 142.0 (C),
1
1
1
7
3
39.6 (CH), 138.9 (CH), 136.8 (C), 131.4 (q, J = 33 Hz, C), 129.1 (CH),
28.8 (CH), 128.4 (CH), 127.5 (CH), 127.1 (CH), 126.7 (CH), 123.9 (CH),
-1
+
257, 1133, 1005, 911, 748, 690, 556, 507 cm . HRMS (ESI ) m/z calcd.
+
for C27
H
25
N
4
O [M + H] : 421.2028; found: 421.2024. [α]
).
D
+178 (c 1.1,
23.4 (q, J = 275 Hz, C), 122.4 (CH), 121.0 (CH), 116.8 (CH), 80.4 (CH),
19
CHCl ). [α]578 +186 (c 1.1, CHCl
3
3
2.7 (CH), 70.9 (CH). F NMR (188 MHz, CDCl
3 3
/CHF ) δ = -63.41. IR:
270, 3247, 3034, 2914, 1588, 1471, 1456, 1369, 1339, 1273, 1173,
-1
(2S,4R,5R)-2-(8-hydroxyquinolin-2-yl)-N,4,5-triphenylimidazolidine-1-
1128, 1008, 977, 899, 882, 759, 740, 697, 680, 629, 529 cm . HRMS
(ESI ) m/z calcd. for C29
[α] +326 (c 1.0, CHCl ). [α]578 +342 (c 1.0, CHCl
+
+
carboxamide 2c. Following general procedure for the preparation of
H
23
F
6
N
4
S [M + H] : 573.1548; found: 573.1542.
).
platforms,the compound 2c was obtained as a white powder with a yield
D
3
3
1
of 66 %. R
f
= 0.71 (AcOEt). Mp = 92 °C. H NMR (300 MHz, CDCl
3
) δ =
8
6
1
1
.13 (d, J = 8.5 Hz, 1H), 7.86 (d, J = 8.5 Hz, 1H), 7.36-6.37 (m, 20H),
(
(
2R,4S,5S)-N’-(3,5-bis(trifluoromethyl)phenyl)-4,5-diphenyl-2-
pyridin-2-yl)imidazolidine-1-carbothioamide 2g-(2R,4S,5S).
.55 (s, 1H), 6.37 (s, 1H), 4.81 (d, J = 7.4 Hz, 1H), 4.43 (d, J = 7.4 Hz,
13
H). C NMR (75 MHz, CDCl
3
) δ = 158.8 (C), 155.0 (C), 152.1 (C),
Following general procedure for the preparation of platforms, the
compound 2g-(2R,4S,5S) was obtained as a white powder with a yield of
38.7 (C), 138.5 (C), 138.2 (C), 137.7 (CH), 137.4 (C), 129.5 (CH), 128.9
1
(
(
CH), 127.3 (CH), 127.1 (CH), 119.5 (CH), 118.2 (CH), 111.0 (CH), 76.3
CH), 71.2 (CH),70.1 (CH) ppm. IR: 3395, 3291, 3053, 3028, 2892, 1651,
6
5 %. R
CDCl
f
= 0.50 (AcOEt/pentane 1/4). Mp = 149 °C. H NMR (300 MHz,
3
) δ = 12.85 (s, 1H), 8.82 (d, J = 4.7 Hz, 1H), 8.21 (s, 2H), 7.98-7.94
m, 2H), 7.55 (s, 1H), 7.49 (t, J = 5.5 Hz, 1H), 7.40 (s, 5H), 7.12 (s, 1H),
1
6
4
596, 1529, 1498, 1441, 1318, 1237, 1156, 1084, 1028, 896, 837, 748,
(
-1
+
+
91, 533, 502 cm . HRMS (ESI ) m/z calcd. for C31
87.2134; found: 487.2139. [α] +185 (c 1.5, CHCl ). [α]578 +190 (c 1.5,
).
27 4 2
H N O [M + H] :
7
.11 (s, 1H), 7.10 (s, 1H), 6.75 (s, 1H), 6.74 (s, 1H), 6.55 (s, 1H), 5.62 (d,
13
D
3
J = 9.1 Hz, 1H), 4.42 (s, 1H), 3.35 (s, 1H). C NMR (75 MHz, CDCl
1
1
) δ =
81.2 (C), 159.4 (C), 148.7 (CH), 142.1 (C), 139.6 (CH), 138.9 (CH),
36.9 (C), 131.3 (q, J = 33 Hz, C), 129.1 (CH), 128.8 (CH), 128.4 (CH),
3
CHCl
3
(
2S,4R,5R)-2-([2,2'-bipyridin]-6-yl)-N’,4,5-triphenylimidazolidine-1-
127.5 (CH), 127.1 (CH), 126.8 (CH), 124.0 (CH), 123.4 (q, J = 271 Hz, C),
19
carboxamide 2d. Following general procedure for the preparation of
platforms, the compound 2d was obtained as a white powder with a yield
of 65 %. R
122.6 (CH), 121.1 (CH), 116.9 (CH), 80.4 (CH), 72.7 (CH), 71.0 (CH).
NMR (188 MHz, CDCl /CHF ) δ -63.40. IR: 3260, 3061, 3033, 2896,
1591, 1471, 1456, 1367, 1342, 1272, 1169, 1127, 1026, 1007, 977, 882,
F
3
3
1
f
= 0.72 (AcOEt). Mp = 171 °C. H NMR (300 MHz, CDCl
3
) δ =
-
1
+
8
(
.75 (s, 1H), 8.43 (d, J = 7.6 Hz, 1H), 8.34 (d, J = 8.0 Hz, 1H), 8.01-7.91
m, 2H), 7.75 (t, J = 7.8 Hz, 1H), 7.38 (s, 6H), 7.28-7.10 (m, 10H), 6.95 (t,
J = 7.1 Hz, 1H), 6.30 (s, 1H), 5.09 (d, J = 8.2 Hz, 1H), 4.46 (d, J = 8.0 Hz,
845, 758, 740, 697, 680, 641, 552, 529 cm . HRMS (ESI ) m/z calcd. for
+
29 23 6 4
C H F N S [M + H] : 573.1548; found: 573.1550.
13
1
3
H), 3.50 (s, 1H). C NMR (75 MHz, CDCl ) δ = 160.0 (C), 155.8 (C),
This article is protected by copyright. All rights reserved.